Clinical Trials Logo

Acellular Pertussis clinical trials

View clinical trials related to Acellular Pertussis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00871741 Terminated - Hepatitis B Clinical Trials

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Start date: April 1, 2009
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine given as a three-dose vaccination course at 3, 5 and 11 months of age.

NCT ID: NCT00544271 Terminated - Tetanus Clinical Trials

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

Start date: May 2003
Phase: Phase 4
Study type: Interventional

To evaluate the immunogenicity, persistence of antibodies and reactogenicity of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX), when administered to subjects 18-20 months old, compared with not giving a booster DTP vaccine at 18-20 months. Study double blinded for the two DTP vaccines and single blinded for the control arm.